Tscan Therapeutics shares owned by EntryPoint Capital
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by EntryPoint Capital
from 13F filings
Historical chart of EntryPoint Capital investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by EntryPoint Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $103k | 21k | 4.98 |